TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Sundrug Co ( (JP:9989) ) has issued an update.
Sundrug Co., Ltd. reported a positive financial performance for the six months ending September 30, 2025, with net sales increasing by 5.8% and profits attributable to owners rising by 7.0% compared to the previous year. The company’s strong financial results reflect its solid market positioning and effective operational strategies, indicating potential growth and stability for stakeholders.
The most recent analyst rating on (JP:9989) stock is a Hold with a Yen5006.00 price target. To see the full list of analyst forecasts on Sundrug Co stock, see the JP:9989 Stock Forecast page.
More about Sundrug Co
Sundrug Co., Ltd. is a company listed on the Tokyo Stock Exchange, primarily operating in the pharmaceutical and retail industry. The company focuses on providing a range of health and wellness products, including pharmaceuticals, cosmetics, and daily essentials, catering to a broad market segment in Japan.
Average Trading Volume: 292,708
Technical Sentiment Signal: Buy
Current Market Cap: Yen503.5B
See more insights into 9989 stock on TipRanks’ Stock Analysis page.